Can Covaxin buck up? India’s primary vaccine under trial for children has to up its production. The wait has been too long

India’s swift crossing of the 75 crore vaccine doses landmark has been powered in large part by Covishield contributing about 67 crore of those doses. Armed with new production lines spread across multiple states, now...

from Times of India Opinion https://ift.tt/3CjbSDF